For more than forty years, Texas Back Institute is committed to providing the highest quality treatments and services for our patients. Our clinical research team stays at the forefront of medical care by initiating studies that advance patient outcomes over time.
Patients can access the latest in clinical studies, peer-reviewed papers, and advanced technology that address trauma, deformity, tumors, and age-related degenerative changes. In some cases, patients are granted access to clinical trials in motion-preserving, minimally invasive and robotics to support their course of treatment
The Spine Biomechanics Laboratory at Texas Back Institute exists to investigate the biomechanical and neuromuscular risk factors associated with spinal ailments in an effort to define the most appropriate and effective treatment options.
This lab is a critical component in bridging the basic science of biomechanics and engineering with the clinical science of spinal care. The clinicians and scientists involved with the lab are uncompromising in furthering the treatment of spinal pathology and translating that knowledge into advanced care to for the patients we serve.
Clinical Research Articles
- “Long-term clinical and radiographic outcomes of cervical disc replacement with the Prestige disc: results from a prospective randomized controlled clinical trial” posted in the Journal Neurosurgery Spine (Dr. Zigler)
- “Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial” posted in the Journal Neurosurgery Spine (Drs. Hisey and Rashbaum)
- “Prospective, Randomized Comparison of Cervical Total Disc Replacement vs. Anterior Cervical Fusion: Results at 48 Months Follow-up” posted in Journal of Spinal Disorders and Techniques (Dr. Hisey)
- “Comparison of 2 Lumbar Total Disc Replacements: Results of a Prospective, Randomized, Controlled, Multicenter Food and Drug Administration Trial With 24-Month Follow-up” posted in the Spine Journal (Dr. Guyer)
- “Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease” posted in The Spine Journal (Dr. Zigler)